Abstract
No public abstract is available from the verified source records.
Lars H. Lund, Bertram Pitt
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial
10.1038/s41591-024-03263-5 · 2024
Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
10.1056/nejmoa2025845 · 2020
FIDELIO-DKD and FIGARO-DKD investigators. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
10.1093/eurheartj/ehab777 · 2022
Finerenone in heart failure with mildly reduced or preserved ejection fraction
10.1056/nejmoa2407107 · 2024
Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function
10.1530/eje.1.01954 · 2005
11beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action
10.1152/physrev.00020.2012 · 2013
The blood-brain barrier in aging and neurodegeneration
10.1038/s41380-022-01511-z · 2022
Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography
10.1016/j.clpt.2006.02.004 · 2006
Brain mineralocorticoid receptor in health and disease: from molecular signalling to cognitive and emotional function
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
10.1111/bph.15835 · 2022
Oxidative stress and mineralocorticoid receptor signaling in the brain: possible therapeutic targets for dementia
2014
Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
10.1186/2040-7378-4-21 · 2012
Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats
10.1016/j.cardiores.2004.08.004 · 2004
The pharmacokinetics of the nonsteroidal mineralocorticoid receptor antagonist finerenone
10.1007/s40262-023-01312-9 · 2023
Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury
10.1097/fjc.0000000000000091 · 2014
Association between use of spironolactone and risk of stroke in hypertensive patients: a cohort study
10.3390/ph16010057 · 2022
No additional external references are available.